CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- PREC14A Other PREC14A
- PREC14A Other PREC14A
- 8-K Event Regulation FD disclosure
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- DFAN14A Other Proxy Soliciting Materials
- 4 Grant or award CEO & President acquired 32,895 shares (grant or award)
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 24,500 shares (grant or award)
- 4 Grant or award COO, Secretary, Gen. Counsel acquired 4,902 shares (grant or award)
- 4 Grant or award CEO & President acquired 49,020 shares (grant or award)
- 8-K Event Material agreement · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
Page 19 of 82 · 1,637 filings